Table 2 The risk score was associated with the Gleason score of patients with PCa in the validation set
Total (N = 138) | Expression | P-value | ||
|---|---|---|---|---|
High_risk (N = 69) | Low_risk (N = 69) | |||
Gleason_Score | ||||
6 | 41 (29.7%) | 18 (26.1%) | 23 (33.3%) | < 0.001 |
7 | 76 (55.1%) | 32 (46.4%) | 44 (63.8%) | |
8 | 11 (8.0%) | 9 (13.0%) | 2 (2.9%) | |
9 | 10 (7.2%) | 10 (14.5%) | 0 (0%) | |
pT | ||||
T2 | 86 (62.3%) | 37 (53.6%) | 49 (71.0%) | 0.093 |
T3 | 45 (32.6%) | 27 (39.1%) | 18 (26.1%) | |
T4 | 7 (5.1%) | 5 (7.2%) | 2 (2.9%) | |